Cancer networks and beyond: Interpreting mutations using the human interactome and protein structure

Seminars in Cancer Biology

Volumn 23, Issue 4, 2013, Pages 219-226

  Gulati, Sakshi ^a   Cheng, Tammy M K ^a   Bates, Paul A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cancer; Mutations; Protein structure; Protein protein interaction networks

Indexed keywords

CANCER GENETICS; CANCER GROWTH; CANCER MUTATION; CANCER PROGNOSIS; CANCER RESEARCH; CANCER SURVIVAL; DATA ANALYSIS; GENE MAPPING; GENE MUTATION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SOMATIC MUTATION; STRUCTURAL BIOINFORMATICS; THREE DIMENSIONAL IMAGING;

EID: 84881117528     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.05.002     Document Type: Review

References (93)

1. Hornberg J.J., Bruggeman F.J., Westerhoff H.V., Lankelma J. Cancer: a Systems Biology disease. Bio Systems 2006, 83:81-90.
2. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
3. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
4. Dalgliesh G.L., Furge K., Greenman C., Chen L., Bignell G., Butler A., et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010, 463:360-363.
5. Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011, 469:539-542.
6. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615.
7. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70.
8. Liu P., Morrison C., Wang L., Xiong D., Vedell P., Cui P., et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis 2012, 33:1270-1276.
9. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993.
10. The Cancer Genome Atlas.
11. Hudson T.J., Anderson W., Artez A., Barker A.D., Bell C., Bernabe R.R., et al. International network of cancer genome projects. Nature 2010, 464:993-998.
12. Hahn W.C., Weinberg R.A. Modelling the molecular circuitry of cancer. Nature Reviews Cancer 2002, 2:331-341.
13. Vogelstein B., Kinzler K.W. Cancer genes and the pathways they control. Nature Medicine 2004, 10:789-799.
14. Kitano H. Systems biology: a brief overview. Science 2002, 295:1662-1664.
15. Wang E., Lenferink A., O'Connor-McCourt M. Cancer systems biology: exploring cancer-associated genes on cellular networks. Cellular and Molecular Life Sciences: CMLS 2007, 64:1752-1762.
16. Kreeger P.K., Lauffenburger D.A. Cancer systems biology: a network modeling perspective. Carcinogenesis 2010, 31:2-8.
17. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine 2012, 366:883-892.
18. Shah S.P., Roth A., Goya R., Oloumi A., Ha G., Zhao Y., et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:395-399.
19. Nik-Zainal S., Van Loo P., Wedge D.C., Alexandrov L.B., Greenman C.D., Lau K.W., et al. The life history of 21 breast cancers. Cell 2012, 149:994-1007.
20. Ding L., Ley T.J., Larson D.E., Miller C.A., Koboldt D.C., Welch J.S., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481:506-510.
21. Yachida S., Jones S., Bozic I., Antal T., Leary R., Fu B., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467:1114-1117.
22. Torkamani A., Schork N.J. Identification of rare cancer driver mutations by network reconstruction. Genome Research 2009, 19:1570-1578.
23. Ideker T., Sharan R. Protein networks in disease. Genome Research 2008, 18:644-652.
24. Jordan F., Nguyen T.P., Liu W.C. Studying protein-protein interaction networks: a systems view on diseases. Briefings in Functional Genomics 2012, 11:497-504.
25. Wachi S., Yoneda K., Wu R. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 2005, 21:4205-4208.
26. Jonsson P.F., Bates P.A. Global topological features of cancer proteins in the human interactome. Bioinformatics 2006, 22:2291-2297.
27. Aragues R., Sander C., Oliva B. Predicting cancer involvement of genes from heterogeneous data. BMC Bioinformatics 2008, 9:172.
28. Pujana M.A., Han J.D., Starita L.M., Stevens K.N., Tewari M., Ahn J.S., et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature Genetics 2007, 39:1338-1349.
29. Chuang H.Y., Lee E., Liu Y.T., Lee D., Ideker T. Network-based classification of breast cancer metastasis. Molecular Systems Biology 2007, 3:140.
30. Efroni S., Schaefer C.F., Buetow K.H. Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS ONE 2007, 2:e425.
31. Kar G., Gursoy A., Keskin O. Human cancer protein-protein interaction network: a structural perspective. PLoS Computational Biology 2009, 5:e1000601.
32. Clarke D., Bhardwaj N., Gerstein M.B. Novel insights through the integration of structural and functional genomics data with protein networks. Journal of Structural Biology 2012, 179:320-326.
33. Kim P.M., Lu L.J., Xia Y., Gerstein M.B. Relating three-dimensional structures to protein networks provides evolutionary insights. Science 2006, 314:1938-1941.
34. Mathivanan S., Periaswamy B., Gandhi T.K., Kandasamy K., Suresh S., Mohmood R., et al. An evaluation of human protein-protein interaction data in the public domain. BMC Bioinformatics 2006, 7(Suppl. 5):S19.
35. Lehne B., Schlitt T. Protein-protein interaction databases: keeping up with growing interactomes. Human Genomics 2009, 3:291-297.
36. De Las Rivas J., Fontanillo C. Protein-protein interactions essentials: key concepts to building and analyzing interactome networks. PLoS Computational Biology 2010, 6:e1000807.
37. Keshava Prasad T.S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., et al. Human Protein Reference Database - 2009 update. Nucleic Acids Research 2009, 37:D767-D772.
38. Kerrien S., Aranda B., Breuza L., Bridge A., Broackes-Carter F., Chen C., et al. The IntAct molecular interaction database in 2012. Nucleic Acids Research 2012, 40:D841-D846.
39. Chatr-Aryamontri A., Breitkreutz B.J., Heinicke S., Boucher L., Winter A., Stark C., et al. The BioGRID interaction database: 2013 update. Nucleic Acids Research 2013, 41:D816-D823.
40. Cowley M.J., Pinese M., Kassahn K.S., Waddell N., Pearson J.V., Grimmond S.M., et al. PINA v2.0: mining interactome modules. Nucleic Acids Research 2012, 40:D862-D865.
41. Franceschini A., Szklarczyk D., Frankild S., Kuhn M., Simonovic M., Roth A., et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Research 2013, 41:D808-D815.
42. Orchard S., Kerrien S., Abbani S., Aranda B., Bhate J., Bidwell S., et al. Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nature Methods 2012, 9:345-350.
43. Huang Y.J., Hang D., Lu L.J., Tong L., Gerstein M.B., Montelione G.T. Targeting the human cancer pathway protein interaction network by structural genomics. Molecular and Cellular Proteomics: MCP 2008, 7:2048-2060.
44. The Cancer Cell Map.
45. Cheng T.M., Gulati S., Agius R., Bates P.A. Understanding cancer mechanisms through network dynamics. Briefings in Functional Genomics 2012, 11:543-560.
46. Shoemaker B.A., Panchenko A.R. Deciphering protein-protein interactions. Part I: experimental techniques and databases. PLoS Computational Biology 2007, 3:e42.
47. Goh K.I., Cusick M.E., Valle D., Childs B., Vidal M., Barabasi A.L. The human disease network. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:8685-8690.
48. Xia J., Sun J., Jia P., Zhao Z. Do cancer proteins really interact strongly in the human protein-protein interaction network. Computational Biology and Chemistry 2011, 35:121-125.
49. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature 1989, 340:245-246.
50. Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., Seraphin B. A generic protein purification method for protein complex characterization and proteome exploration. Nature Biotechnology 1999, 17:1030-1032.
51. Lefebvre C., Rieckhof G., Califano A. Reverse-engineering human regulatory networks. Wiley Interdisciplinary Reviews Systems Biology and Medicine 2012, 4:311-325.
52. Barabasi A.L., Oltvai Z.N. Network biology: understanding the cell's functional organization. Nature Reviews Genetics 2004, 5:101-113.
53. Bader G.D., Hogue C.W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003, 4:2.
54. Reimand J., Tooming L., Peterson H., Adler P., Vilo J. GraphWeb: mining heterogeneous biological networks for gene modules with functional significance. Nucleic Acids Research 2008, 36:W452-W459.
55. Sanz-Pamplona R., Berenguer A., Sole X., Cordero D., Crous-Bou M., Serra-Musach J., et al. Tools for protein-protein interaction network analysis in cancer research. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012, 14:3-14.
56. Kanehisa M., Goto S., Sato Y., Furumichi M., Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research 2012, 40:D109-D114.
57. Kotera M., Hirakawa M., Tokimatsu T., Goto S., Kanehisa M. The KEGG databases and tools facilitating omics analysis: latest developments involving human diseases and pharmaceuticals. Methods in Molecular Biology 2012, 802:19-39.
58. D'Eustachio P. Reactome knowledgebase of human biological pathways and processes. Methods in Molecular Biology 2011, 694:49-61.
59. Guichard C., Amaddeo G., Imbeaud S., Ladeiro Y., Pelletier L., Maad I.B., et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genetics 2012, 44:694-698.
60. Wu G., Feng X., Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biology 2010, 11:R53.
61. Ciriello G., Cerami E., Sander C., Schultz N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Research 2012, 22:398-406.
62. Gu Y., Wang H., Qin Y., Zhang Y., Zhao W., Qi L., et al. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma. Molecular BioSystems 2013, 9:467-477.
63. Taylor I.W., Linding R., Warde-Farley D., Liu Y., Pesquita C., Faria D., et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nature Biotechnology 2009, 27:199-204.
64. Teschendorff A.E., Severini S. Increased entropy of signal transduction in the cancer metastasis phenotype. BMC Systems Biology 2010, 4:104.
65. Carro M.S., Lim W.K., Alvarez M.J., Bollo R.J., Zhao X., Snyder E.Y., et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010, 463:318-325.
66. Lefebvre C., Rajbhandari P., Alvarez M.J., Bandaru P., Lim W.K., Sato M., et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Molecular Systems Biology 2010, 6:377.
67. Wu G., Stein L. A network module-based method for identifying cancer prognostic signatures. Genome Biology 2012, 13:R112.
68. Bair E., Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biology 2004, 2:E108.
69. Zhang W., Ota T., Shridhar V., Chien J., Wu B., Kuang R. Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS Computational Biology 2013, 9:e1002975.
70. Simões-Correia J., Figueiredo J., Lopes R., Stricher F., Oliveira C., Serrano L., et al. E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer. PLoS ONE 2012, 7:e33783.
71. Mah J., Low E., Lee E. In silico SNP analysis and bioinformatics tools: a review of the state of the art to aid drug discovery. Drug Discovery Today 2011, 16:800-809.
72. McCabe M., Graves A., Ganji G., Diaz E., Halsey W., Jiang Y., et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proceedings of the National Academy of Sciences of the United States of America 2012, 109:2989-2994.
73. Janin J. Protein-protein docking tested in blind predictions: the CAPRI experiment. Molecular BioSystems 2010, 6:2351-2362.
74. Moal I.H., Agius R., Bates P.A. Protein-protein binding affinity prediction on a diverse set of structures. Bioinformatics 2011, 27:3002-3009.
75. Vreven T., Hwang H., Pierce B.G., Weng Z. Prediction of protein-protein binding free energies. Protein Science: A Publication of the Protein Society 2012, 21:396-404.
76. Moal I.H., Bates P.A. Kinetic rate constant prediction supports the conformational selection mechanism of protein binding. PLoS Computational Biology 2012, 8:e1002351.
77. Morrow J., Zhang S. Computational prediction of protein hot spot residues. Current Pharmaceutical Design 2012, 18:1255-1265.
78. Thorn K.S., Bogan A.A. ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions. Bioinformatics 2001, 17:284-285.
79. Fischer T.B., Arunachalam K.V., Bailey D., Mangual V., Bakhru S., Russo R., et al. The binding interface database (BID): a compilation of amino acid hot spots in protein interfaces. Bioinformatics 2003, 19:1453-1454.
80. Moal I.H., Fernandez-Recio J. SKEMPI: a Structural Kinetic and Energetic database of Mutant Protein Interactions and its use in empirical models. Bioinformatics 2012, 28:2600-2607.
81. Burke D., Worth C., Priego E., Cheng T., Smink L., Todd J., et al. Genome bioinformatic analysis of nonsynonymous SNPs. BMC Bioinformatics 2007, 8:301.
82. Cavallo A., Martin A. Mapping SNPs to protein sequence and structure data. Bioinformatics 2005, 21:1443-1450.
83. Gong S., Worth C., Cheng T., Blundell T. Meet me halfway: when genomics meets structural bioinformatics. Journal of Cardiovascular Translational Research 2011, 4:281-303.
84. Pieper U., Webb B.M., Barkan D.T., Schneidman-Duhovny D., Schlessinger A., Braberg H., et al. ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Research 2011, 39:D465-D474.
85. de Viron E., Michaux L., Put N., Bontemps F., Van Den Neste E. Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia. Leukemia and Lymphoma 2012, 53:1445-1451.
86. Yates C., Sternberg M. Proteins and domains vary in their tolerance of non-synonymous single nucleotide polymorphisms (nsSNPs). Journal of Molecular Biology 2013, 425:1274-1286.
87. Dawelbait G., Winter C., Zhang Y., Pilarsky C., Grutzmann R., Heinrich J.C., et al. Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data. Bioinformatics 2007, 23:i115-i124.
88. Ward J.J., Sodhi J.S., McGuffin L.J., Buxton B.F., Jones D.T. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. Journal of Molecular Biology 2004, 337:635-645.
89. Csermely P., Sandhu K.S., Hazai E., Hoksza Z., Kiss H.J., Miozzo F., et al. Disordered proteins and network disorder in network descriptions of protein structure, dynamics and function: hypotheses and a comprehensive review. Current Protein and Peptide Science 2012, 13:19-33.
90. Cheng T.M., Goehring L., Jeffery L., Lu Y.E., Hayles J., Novak B., et al. A structural systems biology approach for quantifying the systemic consequences of missense mutations in proteins. PLoS Computational Biology 2012, 8:e1002738.
91. Jucovic M., Hartley R.W. In vivo system for the detection of low level activity barnase mutants. Protein Engineering 1995, 8:497-499.
92. Schreiber G., Frisch C., Fersht A.R. The role of Glu73 of barnase in catalysis and the binding of barstar. Journal of Molecular Biology 1997, 270:111-122.
93. Mosca R., Ceol A., Aloy P. Interactome3D: adding structural details to protein networks. Nature Methods 2013, 10:47-53.